Skip to main content
Clinical Trials/NL-OMON36667
NL-OMON36667
Completed
Not Applicable

Safety and efficacy of a biodegradable stent during neoadjuvant therapy in patients with advanced esophageal cancer. - EsNeBio.

Academisch Medisch Centrum0 sites16 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
esophageal cancer
Sponsor
Academisch Medisch Centrum
Enrollment
16
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \* cT1\-3 N0\-1 M0 esophageal carcinoma.
  • \* Scheduled for neoadjuvant chemoradiation therapy prior to esophagectomy.
  • \* Dysphagia for solid, semisolid or liquid food (dysphagia score 2, 3, 4\).
  • \* Age older then 18 years.
  • \* Informed consent.

Exclusion Criteria

  • \* Tumor length of more than 10 cm.
  • \* Tumor growth within 5 cm of the upper esophageal sphincter.
  • \* Tumor extension into the stomach more than 5 cm.
  • \* Patients with a poor mental condition or mental retardation, unable to understand the nature and possible consequences of the study or unwilling to undergo follow\-up assessments.

Outcomes

Primary Outcomes

Not specified

Similar Trials